RedHill Biopharma RDHL
NASDAQ RDHL
$0.69 +0.04 (+5.31%)
As of: Sep 9, 2026 · 3:59 PM EDT

RedHill Biopharma (RDHL) EBT Margin (QoQ) (2012 - 2023)

Analysis

RedHill Biopharma (RDHL) EBT Margin (QoQ) (2012 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 350,071.00
Mar 31, 2023 32,318.00
Dec 31, 2022 -42,081.00
Sep 30, 2022 -15,842.00
Jun 30, 2022 -6,113.00
Mar 31, 2022 75,523.00
Dec 31, 2021 -72,013.00
Sep 30, 2021 -3,399.00
Jun 30, 2021 3,072.00
Mar 31, 2021 -496.00
Dec 31, 2020 2,120.00
Sep 30, 2020 626.00
Jun 30, 2020 -151,464.00
Mar 31, 2020 81,302.00
Dec 31, 2019 4,118.00
Sep 30, 2019 -18,296.00
Jun 30, 2019 39,367.00
Mar 31, 2019 -42,001.00
Dec 31, 2018 48,697.00
Sep 30, 2018 8,536.00